Regulation of steroid receptor expression by 1α-hydroxyvitamin d5 in hormone-responsive breast cancer cells

Anticancer Research

Volumn 29, Issue 9, 2009, Pages 3555-3561

  Hussain Hakimjee, Erum A ^a   Mehta, Rajendra G ^a,b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^c IIT RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; BT 474 cells; Estrogen receptor; Vitamin D analogs; Vitamin D receptor stability

Indexed keywords

1ALPHA HYDROXYVITAMIN D5; CYCLOHEXIMIDE; DACTINOMYCIN; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; STEROID RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; HORMONE INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 68549140038     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Carlberg C and Seuter S: The vitamin D receptor. Dermatol Clin 25: 515-523, 2007.
2. Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh JC, Salter S and Jurutka PW: Vitamin D receptor: Molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66: S98-S112, 2008.
3. Thorne J and Campbell MJ: The Vitamin D receptor in cancer. Proc Nutr Soc 67: 115-127, 2008.
4. Malloy PJ and Feldman D: Inactivation of the vitamin D receptor by caspase-3. Endocrinology 150: 679-686, 2009.
5. Teichert A, Arnold LA, Otieno S, Oda Y, Augustinaite I, Geistlinger TR, Kriwacki RW, Guy RK and Bikle DD: Quantification of the vitamin D receptor co-regulator interactions. Biochemistry 45: 1454-1464, 2009.
6. DeLuca HF: Evolution of our understanding of vitamin D. Nutr Rev 66: 573-587, 2008.
7. Eelen G, Valle N, Sato Y, Rochel N, Verlinden L, De Clercq P, Moras D, Bouillon R, Munoz A and Versuyf A: Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor. Chem Biol 15: 1029-1034, 2008.
8. 3 up-regulates the renal vitamin D receptors through indirect gene activation and receptor stabilization. Arch Biochem Biophys 433: 466-473, 2005.
9. Xu H, McCann M, Zhang Z, Posner GH, Bignham V, El-Tanani M and Campbell FC: Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals. Mol Carcinog, 2009.
10. Mehta RG, Hawthorne M, Uselding L, Albinascu D, Moriarty R, Christov K and Mehta R: Prevention of N-methyl-N-nitrosourea induced rat mammary carcinogenesis in rats by 1-alpha-hydroxyvitamin D5. J Natl Cancer Inst 92: 1836-1840, 2000.
11. Mehta RG: Stage-specific inhibition of mammary carcinogenesis by 1alpha-hydroxy-vitamin D5. Eur J Cancer 40: 2331-2337, 2004.
12. Lee MJ, Paul S, Atalla N, Thomas PE, Lin X, Yang I, Buckley B, Lu G, Zheng X, Lu YR, Conney AH, Maehr H, Adorini L, Uskokovic M and Suh N: Gemini vitamin D analogs inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcimic activity. Cancer Prev Res 1: 476-484, 2008.
13. Lee J and Safe S: Coactivation of estrogen receptor alpha (ER alpha) Sp1 by vitamin D receptor-interacting protein 150 (DRIP 150). Arch Biochem Biophys 461: 200-210, 2008.
14. Lange CA, Sartorius CA, Abdel-Hafiz H, Spillman MA, Horwitz KB and Jacobson BM: Progesterone receptor action: translating studies in breast cancer models to clinical insight. Adv Exp Med Biol 630: 94-111, 2008.
15. Mehta RG, Moriarty RM, Mehta RR, Penmasta R, Lazzaro G, Constantinou A and Guo L: Prevention of preneopalstic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. J Natl Cancer Inst 89: 212-218, 1997. (Pubitemid 27073758)
16. Hussain EA, Mehta RR, Ray R, Das Gupta TK and Mehta RG: Efficacy and mechanism of action of 1α-hydroxy-24-ethyl-cholecalciferol (1α(OH)D5) in breast cancer prevention and therapy. Recent Results in Cancer Res 4: 476-486, 2003.
17. Hourai S, Rodrigues LC, Antony P, Reina-San-Martin B, Ciesielski F, mangier BC, Schoonjans K, Mourifno, Rochel N and Moras D: Structure-based design of a superagonist ligand for the vitamin D nuclear receptor. Chem Biol 15: 383-392, 2008.
18. Lazzaro G, Agadir A, Qing W, Poria M, Mehta RR, Moriarty RM, Das Gupta TK, Zhang XK and Mehta RG: Induction of differentiation by 1alpha-hydroxy- vitamin D(5) in T47D human breast cancer cells and its interaction with vitamin D receptors. Eur J Cancer 36: 780-786, 2000. (Pubitemid 30179751)
19. Welsh J: Targets of vitamin D receptor signaling in the mammary gland J. Bone Miner res 22(Suppl 2): V86-90 2007.
20. Eelen G, Gyseman C, Verlinden L, Vanoirbeek E, De Clerq P, van Haver D, Mathieu C, Boullion R and Vertuyf A: Mechanism and potential of the growth inhibitory action of vitamin D and analogs. Curr Med Chem 14: 1893-1910, 2007.
21. Bolanz KA, Hediger MA and Landowski CP: The role of TRPV6 in breast carcinogenesis Mol. Cancer Ther 7: 272-279, 2008.
22. Ball LJ, Zhao X, Griffin C, Taglaiferri M, Cohen I, Ricke WA, Speed TP, Firesrone GL and Leitman DC: Cell type and estrogen receptor subtype specific regulation of selective estrogen receptor modulator regulatory elements. Mol Cell Endocrinol 299: 204-211, 2009.
23. Sengupta S and Jordan VC: Selective estrogen modulators as an anticancer tool: Mechanisms of efficiency and resistance. Adv Exptl Med Biol 630: 206-219, 2008.
24. Russo J and Russo IH: The role of estrogen in initiation of breast cancer. J Steroid Biochem Mol Biol 102: 89-96, 2006. (Pubitemid 44750629)
25. Peng X, Jhaveri P, Hussain-Hakimjee EA and Mehta RG: Overexpression of ER and VDR is not sufficient to make ER- negative MDA-MB 231 breast cancer cells responsive to 1α-hydroxy vitamin D5 carcinogenesis 28: 1000-1007, 2007.
26. Christensen GL, Jepsen JS, Fog CK, Christensen IJ and Lykkesfeldt AE: Sequential versus combined treatment of human breast cancer cells with antiestrogens and EB1089 and evaluation of predictive markers of vitamin D treatment. Breast Cancer Res Treat 85: 53-63, 2004.
27. Markicevic M, Petrovic A, Kanjer K, Neskovic Z and Vuskosavujevic D: Estrogen regulated cut-off values of pS2 and cathepsin D expression in breast cancer. Adv Exp Biol 617: 341-318, 2008.
28. Mulholland DJ, Dedhar S., Coetzee GA and Nelson CC: Interaction of nuclear receptors with Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know Endocr. Rev 26: 898-915, 2005. (Pubitemid 41770157)
29. Su Y and Simmen RC: Soy isoflavone genistein up-regulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells Carcinogenesis 30: 331-339, 2009.